Invasive Aspergillosis clinical trials at UC Health
1 research study open to new patients
open to eligible people ages 18 years and up
The purpose of the trial is to evaluate the safety and efficacy of a new antifungal with a novel mechanism of action in immunocompromised adults with invasive aspergillosis.
at UC Davis